{"id":"b4ebb50d-2bc9-52b8-a216-d65927638b19","stable_key":"e37461ea-ea5d-5e2c-8091-138305f6dd70:l-aspartate-ass1-diversion","predicate":"increases_cytosolic_substrate","statement":"Reduced ASS1 activity increased cytosolic aspartate availability and CAD-dependent pyrimidine synthesis in the studied cancer models.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"6a3c273d-02ae-54e3-845c-b75a85afa331","mechanism_event_label":"Using less aspartate for arginine synthesis can leave more for nucleotide synthesis.","subject":{"id":"19970fe9-61b8-5f7c-aac4-fb3eca372d36","slug":"human-tumor-ass1-loss","display_name":"Reduced ASS1 activity in human tumor models","entity_type_key":"cellular_process"},"object":{"id":"0a0923d3-72b7-5d6a-bf3a-5a7a3071a09b","slug":"l-aspartate","display_name":"L-Aspartate","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"6a3c273d-02ae-54e3-845c-b75a85afa331","stable_key":"e37461ea-ea5d-5e2c-8091-138305f6dd70:l-aspartate-ass1-diversion-event","event_type":"observed_relationship","label":"Using less aspartate for arginine synthesis can leave more for nucleotide synthesis.","description":"Reduced ASS1 activity increased cytosolic aspartate availability and CAD-dependent pyrimidine synthesis in the studied cancer models.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"19970fe9-61b8-5f7c-aac4-fb3eca372d36","slug":"human-tumor-ass1-loss","display_name":"Reduced ASS1 activity in human tumor models","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"0a0923d3-72b7-5d6a-bf3a-5a7a3071a09b","slug":"l-aspartate","display_name":"L-Aspartate","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"d46fbb06-9880-57cf-a7eb-1238648cdbb4","slug":"ass1","display_name":"Human argininosuccinate synthetase 1 / ASS1","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"64cc3b93-3e99-5221-bd91-049d190e54c7","slug":"cad","display_name":"Human CAD multifunctional pyrimidine synthesis enzyme","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"f53c7bfb-3b91-56fe-bebd-28623cfe13a0","slug":"citrulline","display_name":"L-Citrulline","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"eeca3c9e-7749-5677-b7bd-37fe8f7c228d","slug":"arginine","display_name":"L-Arginine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human cancer-cell perturbations, metabolic analysis and disease-related comparisons.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The finding does not mean reducing nitrogen disposal is beneficial; it is a tumor-model mechanism.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"l-aspartate","display_name":"L-Aspartate","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Using less aspartate for arginine synthesis can leave more for nucleotide synthesis.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26560030/ · DOI 10.1038/nature15529","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"52d8c26c-5eef-5e93-8d51-ee96718a57be","evidence_kind":"source_excerpt","locator":"Lines 170-176","start_line":170,"end_line":176,"excerpt":"## l-aspartate-ass1-diversion\nUsing less aspartate for arginine synthesis can leave more for nucleotide synthesis.\nReduced ASS1 activity increased cytosolic aspartate availability and CAD-dependent pyrimidine synthesis in the studied cancer models.\nModel: Human cancer-cell perturbations, metabolic analysis and disease-related comparisons.\nLimitations: The finding does not mean reducing nitrogen disposal is beneficial; it is a tumor-model mechanism.\nEvidence access: Primary abstract\nDiversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26560030/ · DOI 10.1038/nature15529","model_system":"Human cancer-cell perturbations, metabolic analysis and disease-related comparisons.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"67970dcb-34e0-5b0a-8c86-d8c3cc183444","stable_key":"import-e37461ea-ea5d-5e2c-8091-138305f6dd70","title":"L-Aspartate: redox transfer, nitrogen partitioning and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"a2791036b8f554be57d0b40892634bb9c900fa03e7e4c9c95ca08428ed52d614","revision_id":"150613bb-a227-5ec9-9f5c-fb13f5da50c8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}